Goldshield in “positive dialogue” with Serious Fraud Office


Goldshield Group, the pharmaceutical and healthcare company, said
in its interim results for the six months to 30 September that it
is making “significant progress” with legal matters.
The group, whose healthcare division includes Vitamins Direct, is
still embroiled in a price-fixing scandal dating back several
years.

The Serious Fraud Office (SFO) began criminal proceedings in
April 2006 against nine individuals (including Goldshield
directors Ajit Patel and Kirti Patel) and five companies alleging
conspiracy to defraud the National Health Service in relation to
the pricing and supply of warfarin, the branded drug Marevan, and
penicillin-based antibiotics between January 1996 and December
2000. In June 2007 the Department of Health and Goldshield agreed
on a settlement, whereby Goldshield would pay £4 million
without admission of liability and continue to cooperate with the
SFO’s criminal investigation.

Share

Twitter Facebook LinkedIn WhatsApp

Related News


CMA clears GXO Clipper deal

Sign up to receive our newsletter